Cite

HARVARD Citation

    Ebadi, M. et al. (2019). Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia. British journal of haematology. pp. e24-e27. [Online]. 
  
Back to record